China: Frontline BioVentures-WuXi Healthcare merger to create $800m fund

Chinese venture capital firms Frontline BioVentures and WuXi Healthcare Ventures have agreed to merge to form a healthcare investment group named 6 Dimensions Capital, which will have combined assets under management (AUM) of RMB 5.5 billion ($800 million).

Continue reading this story with a subscription to DealStreetAsia.